Key facts
- This page summarizes O James Sterling's Form 4 filing for Renalytix plc (RNLXY).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 07 Jul 2023, 16:24.
O James Sterling - 06 Jul 2023 Form 4 Insider Report for Renalytix plc (RNLXY)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RNLXY
- Reported as of
- 06 Jul 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Jul 2023, 16:24:42 UTC
- Prior SEC filing
- 03 Jul 2023
- Next SEC filing
- 13 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Katie Kazem, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
O James Sterling filed Form 4 for Renalytix plc (RNLXY) on 07 Jul 2023.
Change
- Previous filing in this sequence was filed on 03 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RNLX
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +575,160
- Change %
- Price
- $0.000000
- Shares after
- 575,160
- Date
- 06 Jul 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 575,160
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The exercise price is 1.025 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.301 using the Bank of England rate as of July 6, 2023 (1.00 pound sterling = $1.269).
Footnote F2
One twelfth (1/12th) of the shares subject to the option award shall vest in equal quarterly installments commencing on October 6, 2023, subject to the Reporting Person's continuous service.